The World Health Organization (WHO) has just recommended a second vaccine to prevent given seasonally, the vaccine, called R21/Matrix-M or just Matrix-M, is as effective as the previously recommended vaccine, known as RTS, S or Mosquirix. In trials conducted in regions where malaria spread seasonally, three doses of Matrix-M cut the rate of symptomatic malaria in the following year by about 75 per cent. An additional, fourth dose of vaccine given a year after the third dose carries that protection into the next malaria season.
“As a malaria researcher, I used to dream of the day when we would have a safe and effective vaccine against malaria. Now, we have two,” said Tedros Adhanom Ghebreyesus, the current director-general of the WHO. “Demand for the RTS, S vaccine far exceeds supply,…